pyrazines has been researched along with Meningioma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, M; Boehm, C; Ganten, TM; Haas, TL; Holland, H; Keller, M; Koschny, R; Koschny, T; Krupp, W; Meixensberger, J; Mueller, WC; Sinn, P; Sprick, MR; Walczak, H; Xu, LX | 1 |
Antoch, G; Buchbender, C; Nawatny, J | 1 |
2 other study(ies) available for pyrazines and Meningioma
Article | Year |
---|---|
Bortezomib sensitizes primary meningioma cells to TRAIL-induced apoptosis by enhancing formation of the death-inducing signaling complex.
Topics: Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; HEK293 Cells; Humans; Meningioma; Mitochondrial Proteins; Pyrazines; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured | 2014 |
[Meningeal plasmacytoma: delayed diagnosis with sequelae].
Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Brain Edema; Cerebral Hemorrhage; Contrast Media; Delayed Diagnosis; Dexamethasone; Diagnostic Errors; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Multiple Myeloma; Neurologic Examination; Pyrazines; Tomography, X-Ray Computed | 2011 |